Prevalence of cryptococcal antigenuria at initial HIV diagnosis in Kwa Zulu- Natal.

Objectives The World Health Organization ( WHO) recommends screening HIV-infected people for cryptococcal antigens to identify cryptococcosis, a major cause of AIDS-related deaths. As the burden of cryptococcosis is unknown in South Africa's Kwa Zulu- Natal province, we assessed the cryptococcal ant...

Descripción completa

Detalles Bibliográficos
Publicado en:HIV Medicine Vol. 16; no. 10; pp. 640 - 645
Autores principales: Drain, PK, Kleene, JM, Coleman, SM, Losina, E, Katz, JN, Giddy, J, Ross, D, Freedberg, KA, Bassett, IV
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Nov2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110426792&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 110426792
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14642662
        F0I
      jtl: HIV Medicine
      issn: 14642662
      maglogo: Y
    pubinfo:
      dt: Nov2015
      vid: 16
      iid: 10
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        110426792
        110426792
        110426792
        10.1111/hiv.12263
        NLM25958770
        110426792
      ppf: 640
      ppct: 5
      formats:
      tig:
        atl: Prevalence of cryptococcal antigenuria at initial HIV diagnosis in Kwa Zulu- Natal.
      aug:
        au:
          Drain, PK
          Kleene, JM
          Coleman, SM
          Losina, E
          Katz, JN
          Giddy, J
          Ross, D
          Freedberg, KA
          Bassett, IV
        affil: Massachusetts General Hospital, Boston MA, USA
      sug:
        subj:
          Cryptococcosis Epidemiology
          HIV Infections Epidemiology
          Cryptococcosis Urine
          HIV Infections Diagnosis
          South Africa
          Human
          Prevalence
          Cross Sectional Studies
          Outpatients
          Descriptive Statistics
          Adult
          Male
          Female
          Confidence Intervals
          Cryptococcus
          CD4 Lymphocyte Count
          Fisher's Exact Test
          T-Tests
          Mann-Whitney U Test
          Two-Tailed Test
          Data Analysis Software
          Funding Source
          Adult: 19-44 years
          Male
          Female
      ab: Objectives The World Health Organization ( WHO) recommends screening HIV-infected people for cryptococcal antigens to identify cryptococcosis, a major cause of AIDS-related deaths. As the burden of cryptococcosis is unknown in South Africa's Kwa Zulu- Natal province, we assessed the cryptococcal antigenuria prevalence among newly diagnosed HIV-infected adults there. Methods We conducted a cross-sectional study of newly diagnosed HIV-infected adults who received voluntary HIV testing in an out-patient clinic. Participants provided a urine specimen in a sterile container, and we performed testing with a WHO-endorsed rapid cryptococcal antigen lateral flow assay ( Immy Inc., Norman, OK, USA) per the manufacturer's specifications. We assessed cryptococcal antigenuria prevalence among participants with CD4 counts < 200 cells/μL, and stratified results by CD4 count categories. Results Among 432 participants, the mean (± standard deviation) age was 36.1 ± 9.9 years and 172 (40%) were female. The overall estimated prevalence of cryptococcal antigenuria was 9.0% [95% confidence interval ( CI) 6.5-12.1%]. CD4 counts were available for 319 participants (74%); the median CD4 count was 75 cells/μL [interquartile range ( IQR) 34-129 cells/μL]. Participants with a negative cryptococcal antigenuria screening test had a median CD4 count of 79 cells/μL ( IQR 36-129 cells/μL), while participants with a positive cryptococcal test had a median CD4 count of 41 cells/μL ( IQR 10-112 cells/μL). The estimated prevalence of cryptococcal antigenuria among participants with CD4 counts < 50 cells/μL was 12.5% (95% CI 7.0-20.1%), which was significantly higher than that among participants with CD4 counts of 50-200 cells/μL (4.8%; 95% CI 2.3-8.7%). Conclusions Nearly 1 in 10 newly diagnosed HIV-infected adults with CD4 counts < 200 cells/μL in Kwa Zulu-Natal had evidence of cryptococcal antigenuria. Point-of-care CD4 count testing and cryptococcal antigen screening may rapidly identify cryptococcosis at the time of HIV diagnosis.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N